MMG49 Identified as a New Target in Multiple Myeloma

MMG49 has been identified as a monoclonal antibody that can be targeted using CAR T-cell therapy for patients with multiple myeloma.

Source: CancerNetwork - December 13, 2017 Category: Cancer & Oncology Authors: John Schieszer Tags: Hematologic Cancer Targets Immuno Oncology Multiple Myeloma News Source Type: news